MoneyWorks4Me

NGL Fine-Chem submits annual report

27 Jul 2019 Evaluate

NGL Fine-Chem has informed about submission of the Annual Report containing the Director’s Report and its annexures, Management Discussion and Analysis Report, Corporate Governance Report and Audited Financial Statements along with the Notice of 38th Annual General Meeting of the Company for the financial year ended on 31st March, 2019. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..